Skip to content

An randomized controlled study on xerostomia induced by fluorouracil chemotherapy in patients with gastrointestinal tumors

An randomized controlled study on xerostomia induced by fluorouracil chemotherapy in patients with gastrointestinal tumors

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034729
Enrollment
Unknown
Registered
2020-07-16
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

xerostomia caused by chemotherapy

Interventions

dark plum juice group:dark plum juice group
mint and lemon juice group:mint and lemon juice group
Control Group:none

Sponsors

Fujian Cancer Hospital & Fujian Medical University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Pathological diagnosis of digestive tract tumors. 2.Patients were treated with fluorouracil and the survival time was more than 6 months. 3.Tolerate the taste of plum, licorice and lemon, and have no allergy or adverse reactions.Patients' informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with stomatitis or xerostomia before chemotherapy. 2. Complicated with cardiovascular, liver, kidney and hematopoietic system and other serious primary diseases as well as diabetes and depression, psychiatric patients. 3. Cannot gargle through the mouth. 4. Recent history of diseases and medication that affect salivary gland function.

Design outcomes

Primary

MeasureTime frame
unstimulated whole saliva;Linear visual simulation scoring;EORTC QLQ—C30;

Countries

China

Contacts

Public ContactChen Zhuoyan

Department of Medical Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital

304909247@qq.com+86 15959084182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026